These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3877670)

  • 1. [Use of the paramunity inducer PIND-AVI in reduced cell-mediated immunocompetence. Immunoreconstitution following cytostatic chemotherapy].
    Stickl H; Schleich T
    Fortschr Med; 1985 Oct; 103(39):907-9. PubMed ID: 3877670
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of a new "paramunity" inducer (PIND-AVI) for human beings and animals].
    Stickl H; Mayr A
    Fortschr Med; 1979 Oct; 97(40):1781-8. PubMed ID: 232054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart weapons.
    Kraco K
    Minn Med; 2004 May; 87(5):28-32. PubMed ID: 15191065
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of the paramunity inducers PIND-AVI and PIND-ORF as radioprotective agents].
    Breiter N; Ungemach FR; Beck G; Hegner D; Mayr A
    Strahlentherapie; 1985 Mar; 161(3):168-76. PubMed ID: 3975952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies of the efficacy of paramunity inducer PIND-AVI, mitogen PHA-P and rhinopneumonitis virus on peripheral leukocytes in the horse].
    Thein P; Hechler H; Mayr A
    Zentralbl Veterinarmed B; 1981; 28(6):432-49. PubMed ID: 6275637
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction of immunologic deficiency by benzene and its correction by administration of anabol].
    Karaulov AV; Ogarkov VI; Khromenkov IuI; Frash VN
    Biull Eksp Biol Med; 1988 Apr; 105(4):457-9. PubMed ID: 3359030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioprotective effectiveness of the paramunity inducer "pind-avi": investigation using the model "protective tetanic vaccination in mice" after exposure to X-rays (author's transl)].
    Mayr A; Baljer G; Sailer J; Schels D
    Strahlentherapie; 1980 Nov; 156(11):795-9. PubMed ID: 6254210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The protocol in immunodeficiencies following chemotherapy].
    Urda Cardona A; Acha T; Bueno A
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():176-9. PubMed ID: 2490618
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of the paramunity inducer PIND-ORF on the elimination of coccidial oocysts from normal and immunosuppressed carrier pigeons (Columba livia Gmel., 1789, var. dom.)].
    Haas L; Kösters J
    Zentralbl Veterinarmed B; 1987 Jul; 34(5):333-40. PubMed ID: 3687287
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with paramunization in birds].
    Schneeganss D
    Tierarztl Prax; 1989; 17(3):293-5. PubMed ID: 2815068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infectious pathology in immunodepressed patients as a consequence of antineoplastic treatment].
    Sánchez de Toledo Codina J
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():172-6. PubMed ID: 2490617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of cytostatic chemotherapy on delayed hypersensitivity reaction].
    Schneider M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):877-80. PubMed ID: 5709511
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interleukins as modulators of the immune system].
    Röllinghoff M
    Ric Clin Lab; 1984; 14 Suppl 2():15-20. PubMed ID: 6241743
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of paramunity inducers in small animal practice].
    Proksch AL; Hartmann K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2016; 44(2):129-34. PubMed ID: 26998822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytostatic agents and defense].
    Sauter C
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1145-50. PubMed ID: 3532312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological aspects of lymphogranulomatosis].
    Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO
    Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Brief notes on the contribution of the immunology laboratory to the chemotherapy department].
    Pinto AS
    Arq Patol; 1973 Apr; 45(1):17-21. PubMed ID: 4588745
    [No Abstract]   [Full Text] [Related]  

  • 18. Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies.
    Aiuti F; Lacava V; Garofalo JA; D'Amelio R; D'Asero C
    Clin Exp Immunol; 1973 Sep; 15(1):43-52. PubMed ID: 4587827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
    Morecki S; Gelfand Y; Nagler A; Or R; Naparstek E; Varadi G; Engelhard D; Akerstein A; Slavin S
    Bone Marrow Transplant; 2001 Aug; 28(3):243-9. PubMed ID: 11535991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Di George syndrome treated with thymopoietin pentapeptide (TP-5) demonstrating an adherent suppressor cell of lymphocyte function.
    Joffe MI; Sochett E; Pettifor JM; Rabson AR
    J Clin Lab Immunol; 1982 May; 8(1):69-73. PubMed ID: 6212686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.